These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3102725)

  • 21. Latent human leukocyte collagenase can be activated by gold thioglucose and gold sodium thiomalate, but not by auranofin.
    Sorsa T; Suomalainen K; Turto H; Lindy S
    Biosci Rep; 1987 Dec; 7(12):965-8. PubMed ID: 2840130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
    Batlle Gualda E
    Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
    [No Abstract]   [Full Text] [Related]  

  • 23. [The detection of gold atoms in lymphocyte and erythrocyte chromatin following therapy with 2 different gold compounds in patients with chronic polyarthritis].
    Bröll H; Tausch G; Teherani DK
    Wien Klin Wochenschr Suppl; 1984; 156():16. PubMed ID: 6442049
    [No Abstract]   [Full Text] [Related]  

  • 24. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E
    Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
    [No Abstract]   [Full Text] [Related]  

  • 25. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
    Wessel J; Davis P
    J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
    [No Abstract]   [Full Text] [Related]  

  • 26. One-year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate, and placebo.
    Williams HJ; Dahl SL; Ward JR; Karg M; Willkens RF; Meenan RF; Altz-Smith M; Clegg DO; Mikkelsen WM; Kay DR
    Arthritis Rheum; 1988 Jan; 31(1):9-14. PubMed ID: 3125841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study.
    Harth M; Davis P; Thompson JM; Menard H; Beaudet F
    Scand J Rheumatol; 1987; 16(3):177-84. PubMed ID: 3110944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 6. Bucillamine and gold (gold sodium thiomalate and auranofin)].
    Ito S
    Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2936-41. PubMed ID: 22175134
    [No Abstract]   [Full Text] [Related]  

  • 29. Gold(I) ion and the phosphine ligand are necessary for the anti-
    Ma CI; Tirtorahardjo JA; Schweizer SS; Zhang J; Fang Z; Xing L; Xu M; Herman DA; Kleinman MT; McCullough BS; Barrios AM; Andrade RM
    Microbiol Spectr; 2024 Feb; 12(2):e0296823. PubMed ID: 38206030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocrisin.
    Capell HA
    Agents Actions Suppl; 1988; 24():158-66. PubMed ID: 3142232
    [No Abstract]   [Full Text] [Related]  

  • 31. The in vivo effect of triethylphosphine gold (auranofin), sodium aurothiomalate and azathioprine on lymphocyte subsets of patients with rheumatoid arthritis.
    Pedersen BK; Abom B
    Allergy; 1988 Jul; 43(5):396-8. PubMed ID: 2970811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with auranofin in patients with rheumatoid arthritis, previously experiencing drug related side effects to sodium aurothiomalate.
    Davis P; Landon M
    J Rheumatol; 1985 Jun; 12(3):622. PubMed ID: 3930724
    [No Abstract]   [Full Text] [Related]  

  • 33. Auranofin.
    Davis P
    Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bimodal effect of gold on IL-1 production by blood monocytes.
    Danis VA; Kulesz A; Nelson DS; Brooks PM
    J Rheumatol; 1989 Aug; 16(8):1160-1. PubMed ID: 2511304
    [No Abstract]   [Full Text] [Related]  

  • 35. Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: a one-year, double-blind, comparative multicenter study.
    Schattenkirchner M; Bröll H; Kaik B; Müller-Fassbender H; Rau R; Zeidler H
    Klin Wochenschr; 1988 Feb; 66(4):167-74. PubMed ID: 3131571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacology of gold.
    Kean WF; Kean IR
    Inflammopharmacology; 2008 Jun; 16(3):112-25. PubMed ID: 18523733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The pharmacology of gold compounds].
    Juan H
    Wien Klin Wochenschr Suppl; 1984; 156():7-13. PubMed ID: 6442062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M; Keown PA; Orange J
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organic gold compounds in the treatment of rheumatoid arthritis.
    Rooney TW; Furst DE
    Iowa Med; 1985 Feb; 75(2):74-7. PubMed ID: 3918952
    [No Abstract]   [Full Text] [Related]  

  • 40. Gold--by mouth?
    Symmons D
    J Clin Pharm Ther; 1989 Aug; 14(4):243-5. PubMed ID: 2571615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.